Leerink Partners Raises Price Target on Medtronic (MDT) Following 4Q Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Wedbush Raises Price Target on Medtronic (MDT) to $82 Following 4Q Report
June 1, 2016 8:41 AM EDTWedbush reiterated a Neutral rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $82.00 (from $79.00), following the company's 4Q earnings report. MDT reported revenue of $7,567 million, beating the consensus revenue estimate of $7,479 million and was above the upper end of guidance at... More
BTIG Downgrades Medtronic, Inc. (MDT) to Neutral
June 1, 2016 7:18 AM EDTBTIG downgraded Medtronic, Inc. (NYSE: MDT) from Buy to Neutral. Analyst Sean Lavin sees valuation as full and he noted disappointing margins.
"Foremost, at ~$80 we feel valuation is full and no longer see 15% upside over the next 12 months. We also feel... More
Medtronic (MDT): In-Line Quarter, Raising PT - Piper Jaffray
June 1, 2016 6:58 AM EDTPiper Jaffray analyst, Brooks West, raised his PT on Medtronic (NYSE: MDT) to $93 from $85 after the company reported F4Q revenue of $7.57B (+6%cc) vs. consensus of $7.49B. EPS of $1.27, was $0.01 above consensus but the Streets expectation for 300bp of sequential operating leverage... More
Medtronic (MDT) Tops Q4 EPS by 1c
May 31, 2016 6:47 AM EDTMedtronic (NYSE: MDT) reported Q4 EPS of $1.27, $0.01 better than the analyst estimate of $1.26. Revenue for the quarter came in at $7.57 billion versus the consensus estimate of $7.49 billion.
GUIDANCE:
Medtronic sees FY2017 EPS of $4.60-$4.70, versus the consensus of $4.70.
In fiscal... More
